TrialBreast cancer research : BCR2016

Efficacy and safety of palbociclib in combination with letrozole as first-line treatment of ER-positive, HER2-negative, advanced breast cancer: expanded analyses of subgroups from the randomized pivotal trial PALOMA-1/TRIO-18.

Richard S Finn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.